Individualized molecular medicine: linking functional proteomics to select therapeutics targeting the PI3K pathway for specific patients

Adv Exp Med Biol. 2008;622:183-95. doi: 10.1007/978-0-387-68969-2_15.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / analysis*
  • Clinical Trials as Topic
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / enzymology
  • Phosphatidylinositol 3-Kinases*
  • Proteomics / methods*
  • Proteomics / trends

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Phosphatidylinositol 3-Kinases